DNMT3A and cancer: Overexpression of LinC00472 can recruit DNMT1, DNMT3A and DNMT3B to mediate the methylation of oncogenic factor MCM6, which leads to the down-regulation of its expression level, and then inhibits cancer progression by inactivating MEK/ERK signaling pathway (89).